PAPER Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg WH, Engelborghs S, De Deyn PP
SEARCH RESULTS
330988 RESULTS
PAPER Liu Y, Zhang M, Hao W, Mihaljevic I, Liu X, Xie K, Walter S, Fassbender K
Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain.
Neurobiol Aging. 2013 Apr;34(4):1231-9. PubMed: 23159549PAPER Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ
Epidemiology of dementias and Alzheimer's disease.
Arch Med Res. 2012 Nov;43(8):600-8. PubMed: 23159715PAPER Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K
Brain expression level and activity of HDAC6 protein in neurodegenerative dementia.
Biochem Biophys Res Commun. 2013 Jan 4;430(1):394-9. PubMed: 23159615PAPER Lee S, Shea TB
Regulation of tau proteolysis by phosphatases.
Brain Res. 2013 Feb 7;1495:30-6. PubMed: 23159717PAPER Wiart C
A note on the relevance of [6]-Gingerol for the prevention and/or treatment of Alzheimer's disease.
Food Chem Toxicol. 2013 Jan;51:456. PubMed: 23159913PAPER Wittwer JE, Webster KE, Hill K
Effect of Rhythmic Auditory Cueing on Gait in People With Alzheimer Disease.
Arch Phys Med Rehabil. 2012 Nov 13; PubMed: 23159787PAPER Yokota T, Akatsu H, Miyauchi T, Heese K
Characterization of the novel protein P9TLDR (temporal lobe down-regulated) with a brain-site-specific gene expression modality in Alzheimer's disease brain.
FEBS Lett. 2012 Dec 14;586(24):4357-61. PubMed: 23159938PAPER Montañés M, Casabona D, Sarasa L, Pesini P, Sarasa M
Prevention of Amyloid-β Fibril Formation Using Antibodies Against the C-terminal Region of Amyloid-β1-40 and Amyloid-β1-42.
J Alzheimers Dis. 2013 Jan 1;34(1):133-7. PubMed: 23160008PAPER Gupta VB, Monica FS, Berrocal R, Rao KS
Studies on the Mechanism of the DNA Nicking Property of Amyloid-β40: Implications in Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;33(4):1059-71. PubMed: 23160010PAPER Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P
Cognitive Decline in Adults with Amnestic Mild Cognitive Impairment and High Amyloid-β: Prodromal Alzheimer's Disease?
J Alzheimers Dis. 2013 Jan 1;33(4):1167-76. PubMed: 23160011PAPER Zhang L, Yu S, Zhang R, Xing Y, Li Y, Li L
Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease.
Restor Neurol Neurosci. 2013 Jan 1;31(1):41-52. PubMed: 23160059PAPER Singh S, Kushwah AS, Singh R, Farswan M, Kaur R
Current therapeutic strategy in Alzheimer's disease.
Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1651-64. PubMed: 23161037PAPER Albertini V, Benussi L, Paterlini A, Glionna M, Prestia A, Bocchio-Chiavetto L, Amicucci G, Galluzzi S, Adorni A, Geroldi C, Binetti G, Frisoni GB, Ghidoni R
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia.
Electrophoresis. 2012 Dec;33(24):3738-44. PubMed: 23161113PAPER Cai Z, Yan LJ, Ratka A
Telomere Shortening and Alzheimer's Disease.
Neuromolecular Med. 2012 Nov 16; PubMed: 23161153Current Filters
No filters selected